Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1081-1090 of 1,467) with videos related to

Pageof 147
Sort By:
RMD Open|October 12, 2017
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate aloneEdward C Keystone, Ferdinand C Breedveld, Désirée van der Heijde, et al.
RMD Open|September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritisLaura C Coates, Josef S Smolen, Philip J Mease, et al.
Postgraduate Medicine|December 20, 2014
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addictsKenneth Blum, Yijun Liu, Wei Wang, et al.
Rheumatology and Therapy|January 21, 2026
Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc AnalysisTsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, et al.
Seminars in Arthritis and Rheumatism|July 26, 2015
Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohortHelga Radner, Kazuki Yoshida, Maria Dahl Mjaavatten, et al.
RMD Open|February 27, 2020
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritisMasayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Lancet (London, England)|May 28, 2019
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 studyJosef S Smolen, Aileen L Pangan, Paul Emery, et al.
The Journal of Rheumatology|March 3, 2011
Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trialEdward C Keystone, Jeffrey R Curtis, Roy M Fleischmann, et al.
ACS Infectious Diseases|November 17, 2017
Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase InhibitorsEmilia Caselli, Chiara Romagnoli, Rachel A Powers, et al.
Pageof 147

Showing results (1081-1090 of 1,467) with videos related to

Sort By:
Pageof 147
RMD Open|October 12, 2017
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate aloneEdward C Keystone, Ferdinand C Breedveld, Désirée van der Heijde, et al.
RMD Open|September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritisLaura C Coates, Josef S Smolen, Philip J Mease, et al.
Postgraduate Medicine|December 20, 2014
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addictsKenneth Blum, Yijun Liu, Wei Wang, et al.
Rheumatology and Therapy|January 21, 2026
Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc AnalysisTsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, et al.
Seminars in Arthritis and Rheumatism|July 26, 2015
Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohortHelga Radner, Kazuki Yoshida, Maria Dahl Mjaavatten, et al.
RMD Open|February 27, 2020
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritisMasayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Lancet (London, England)|May 28, 2019
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 studyJosef S Smolen, Aileen L Pangan, Paul Emery, et al.
The Journal of Rheumatology|March 3, 2011
Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trialEdward C Keystone, Jeffrey R Curtis, Roy M Fleischmann, et al.
ACS Infectious Diseases|November 17, 2017
Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase InhibitorsEmilia Caselli, Chiara Romagnoli, Rachel A Powers, et al.
Pageof 147